“Long-Term Safety, Tolerability, and Efficacy of Vismodegib in Two Patients With Metastatic Basal Cell Carcinoma and Basal Cell Nevus Syndrome”. Dermatology Reports 3, no. 3 (December 1, 2011): e55. Accessed June 18, 2025. https://journals.pagepress.org/dr/article/view/dr.2011.e55.